Literature DB >> 31930993

Health resource utilization of labor induction versus expectant management.

William A Grobman1, Grecio Sandoval2, Uma M Reddy3, Alan T N Tita4, Robert M Silver5, Gail Mallett6, Kim Hill5, Madeline Murguia Rice2, Yasser Y El-Sayed7, Ronald J Wapner8, Dwight J Rouse9, George R Saade10, John M Thorp11, Suneet P Chauhan12, Jay D Iams13, Edward K Chien14, Brian M Casey15, Ronald S Gibbs16, Sindhu K Srinivas17, Geeta K Swamy18, Hyagriv N Simhan19, George A Macones20.   

Abstract

BACKGROUND: Although induction of labor of low-risk nulliparous women at 39 weeks reduces the risk of cesarean delivery compared with expectant management, concern regarding more frequent use of labor induction remains, given that this intervention historically has been thought to incur greater resource utilization.
OBJECTIVE: The objective of the study was to determine whether planned elective labor induction at 39 weeks among low-risk nulliparous women, compared with expectant management, was associated with differences in health care resource utilization from the time of randomization through 8 weeks postpartum. STUDY
DESIGN: This is a planned secondary analysis of a multicenter randomized trial in which low-risk nulliparous women were assigned to induction of labor at 39 weeks or expectant management. We assessed resource utilization after randomization in 3 time periods: antepartum, delivery admission, and discharge through 8 weeks postpartum.
RESULTS: Of 6096 women with data available, those in the induction of labor group (n = 3059) were significantly less likely in the antepartum period after randomization to have at least 1 ambulatory visit for routine prenatal care (32.4% vs 68.4%), unanticipated care (0.5% vs 2.6%), or urgent care (16.2% vs 44.3%), or at least 1 antepartum hospitalization (0.8% vs 2.2%, P < .001 for all). They also had fewer tests (eg, sonograms, blood tests) and treatments (eg, antibiotics, intravenous hydration) prior to delivery. During the delivery admission, women in the induction of labor group spent a longer time in labor and delivery (median, 0.83 vs 0.57 days), but both women (P = .002) and their neonates (P < .001) had shorter postpartum stays. Women and neonates in both groups had similar frequencies of postpartum urgent care and hospital readmissions (P > .05 for all).
CONCLUSION: Women randomized to induction of labor had longer durations in labor and delivery but significantly fewer antepartum visits, tests, and treatments and shorter maternal and neonatal hospital durations after delivery. These results demonstrate that the health outcome advantages associated with induction of labor are gained without incurring uniformly greater health care resource use.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cesarean delivery; costs; expectant management; induction of labor; resources

Mesh:

Substances:

Year:  2020        PMID: 31930993      PMCID: PMC7141954          DOI: 10.1016/j.ajog.2020.01.002

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Intervention rates after elective induction of labor compared to labor with a spontaneous onset. A matched cohort study.

Authors:  N van Gemund; A Hardeman; S A Scherjon; H H H Kanhai
Journal:  Gynecol Obstet Invest       Date:  2003-09-29       Impact factor: 2.031

2.  Induction of labor and cesarean delivery by gestational age.

Authors:  Aaron B Caughey; James M Nicholson; Yvonne W Cheng; Deirdre J Lyell; A Eugene Washington
Journal:  Am J Obstet Gynecol       Date:  2006-09       Impact factor: 8.661

3.  SMFM Statement on Elective Induction of Labor in Low-Risk Nulliparous Women at Term: the ARRIVE Trial.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2018-08-09       Impact factor: 8.661

4.  Outcome after elective labor induction in nulliparous women: a matched cohort study.

Authors:  Hendrik Cammu; Guy Martens; Gunther Ruyssinck; Jean-Jacques Amy
Journal:  Am J Obstet Gynecol       Date:  2002-02       Impact factor: 8.661

5.  Economic implications of method of delivery.

Authors:  Victoria M Allen; Colleen M O'Connell; Scott A Farrell; Thomas F Baskett
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

6.  Risk of cesarean delivery with elective induction of labor at term in nulliparous women.

Authors:  S T Seyb; R J Berka; M L Socol; S L Dooley
Journal:  Obstet Gynecol       Date:  1999-10       Impact factor: 7.661

7.  Costing the cascade: estimating the cost of increased obstetric intervention in childbirth using population data.

Authors:  Sally K Tracy; Mark B Tracy
Journal:  BJOG       Date:  2003-08       Impact factor: 6.531

8.  Cost-effectiveness of induction of labour versus serial antenatal monitoring in the Canadian Multicentre Postterm Pregnancy Trial.

Authors:  R Goeree; M Hannah; S Hewson
Journal:  CMAJ       Date:  1995-05-01       Impact factor: 8.262

9.  Labor Induction versus Expectant Management in Low-Risk Nulliparous Women.

Authors:  William A Grobman; Madeline M Rice; Uma M Reddy; Alan T N Tita; Robert M Silver; Gail Mallett; Kim Hill; Elizabeth A Thom; Yasser Y El-Sayed; Annette Perez-Delboy; Dwight J Rouse; George R Saade; Kim A Boggess; Suneet P Chauhan; Jay D Iams; Edward K Chien; Brian M Casey; Ronald S Gibbs; Sindhu K Srinivas; Geeta K Swamy; Hyagriv N Simhan; George A Macones
Journal:  N Engl J Med       Date:  2018-08-09       Impact factor: 91.245

10.  Labour induction near term for women aged 35 or over: an economic evaluation.

Authors:  K F Walker; M Dritsaki; G Bugg; M Macpherson; C McCormick; N Grace; C Wildsmith; L Bradshaw; Gcs Smith; J G Thornton
Journal:  BJOG       Date:  2017-03-16       Impact factor: 6.531

View more
  8 in total

1.  Association of Body Mass Index With the Use of Health Care Resources in Low-Risk Nulliparous Pregnancies After 39 Weeks of Gestation.

Authors:  Maged M Costantine; Grecio J Sandoval; William A Grobman; Uma M Reddy; Alan T N Tita; Robert M Silver; Yasser Y El-Sayed; Ronald J Wapner; Dwight J Rouse; George R Saade; John M Thorp; Suneet P Chauhan; Edward K Chien; Brian M Casey; Sindhu K Srinivas; Geeta K Swamy; Hyagriv N Simhan
Journal:  Obstet Gynecol       Date:  2022-04-05       Impact factor: 7.623

2.  Induction of labour at or beyond 37 weeks' gestation.

Authors:  Philippa Middleton; Emily Shepherd; Jonathan Morris; Caroline A Crowther; Judith C Gomersall
Journal:  Cochrane Database Syst Rev       Date:  2020-07-15

Review 3.  American College of Nurse-Midwives Clinical Bulletin Number 18: Induction of Labor.

Authors:  Nicole Smith Carlson; Alexis Dunn Amore; Jessica Ann Ellis; Katie Page; Robyn Schafer
Journal:  J Midwifery Womens Health       Date:  2022-01       Impact factor: 2.891

4.  Head in the sand: Contemporary Australian attitudes towards induction of labour.

Authors:  Harsha Ananthram; Ajay Rane
Journal:  Aust N Z J Obstet Gynaecol       Date:  2022-03-15       Impact factor: 1.884

5.  Out-of-Hospital Cervical Ripening With a Synthetic Hygroscopic Cervical Dilator May Reduce Hospital Costs and Cesarean Sections in the United States-A Cost-Consequence Analysis.

Authors:  Sita J Saunders; Rhodri Saunders; Tess Wong; Antonio F Saad
Journal:  Front Public Health       Date:  2021-06-18

6.  Labor Induction at 39 Weeks Compared with Expectant Management in Low-Risk Parous Women.

Authors:  Stephen M Wagner; Grecio Sandoval; William A Grobman; Jennifer L Bailit; Ronald J Wapner; Michael W Varner; John M Thorp; Mona Prasad; Alan T N Tita; George R Saade; Yoram Sorokin; Dwight J Rouse; Jorge E Tolosa
Journal:  Am J Perinatol       Date:  2020-09-11       Impact factor: 3.079

7.  Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women.

Authors:  Brett D Einerson; Richard E Nelson; Grecio Sandoval; M Sean Esplin; D Ware Branch; Torri D Metz; Robert M Silver; William A Grobman; Uma M Reddy; Michael Varner
Journal:  Obstet Gynecol       Date:  2020-07       Impact factor: 7.623

8.  Outpatient Cervical Ripening With Misoprostol in Low-Risk Pregnancies.

Authors:  Kristina Roloff; Kristina Nalbandyan; Suzanne Cao; C Camille Okekpe; Inessa Dombrovsky; Guillermo J Valenzuela
Journal:  Cureus       Date:  2021-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.